ARTICLE | Company News
BioFocus, Australian Cancer in oncology deal
July 11, 2001 7:00 AM UTC
BioFocus (LSE:BIO) and Australian Cancer Technologies (Sydney, Australia) will develop small molecule tyrosine kinase receptor modulators for use in treating breast cancer. BIO will contribute its Ret...